Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. Oktober 2011 17:30 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Extension of Temporary Restraining Order Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.

CAMBRIDGE, Mass., Oct. 21, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
17. Oktober 2011 17:03 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at the BioCentury NewsMakers Conference

CAMBRIDGE, Mass., Oct. 17, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
07. Oktober 2011 16:15 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Obtains Temporary Restraining Order Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.

CAMBRIDGE, Mass., Oct. 7, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
30. September 2011 16:10 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Files for Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.

CAMBRIDGE, Mass., Sept. 30, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
21. September 2011 17:22 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Sues Amphastar for Patent Infringement

CAMBRIDGE, Mass., Sept. 21, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
19. September 2011 17:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at the UBS Global Life Sciences Conference and Pharmaceutical Strategic Alliances Conference

CAMBRIDGE, Mass., Sept. 19, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
08. September 2011 16:45 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investment Conferences

CAMBRIDGE, Mass., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
16. August 2011 08:30 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at the 2011 Wedbush Life Sciences Management Access Conference

CAMBRIDGE, Mass., Aug. 16, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
08. August 2011 16:30 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at the 2011 Canaccord Genuity Growth Conference

CAMBRIDGE, Mass., Aug. 8, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
04. August 2011 08:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports $1.26 Earnings Per Share for the Second Quarter of 2011

CAMBRIDGE, Mass., Aug. 4, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...

Vorherige Seite

Nächste Seite